Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1988 Feb;62(2):488–495. doi: 10.1128/jvi.62.2.488-495.1988

Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

M H Snyder 1, R F Betts 1, D DeBorde 1, E L Tierney 1, M L Clements 1, D Herrington 1, S D Sears 1, R Dolin 1, H F Maassab 1, B R Murphy 1
PMCID: PMC250559  PMID: 3336068

Abstract

Clinical studies previously demonstrated that live influenza A virus vaccines derived by genetic reassortment from the mating of influenza A/Ann Arbor/6/60 (H2N2) cold-adapted (ca) donor virus with epidemic wild-type influenza A viruses are reproducibly safe, infectious, immunogenic, and efficacious in the prevention of illness caused by challenge with virulent wild-type virus. These influenza A reassortant virus vaccines also express the ca and temperature sensitivity (ts) phenotypes in vitro, but the genes of the ca virus parent which specify the ca, ts, and attenuation (att) phenotypes have not adequately been defined. To identify the genes associated with each of these phenotypes, we isolated six single-gene substitution reassortant viruses, each of which inherited only one RNA segment from the ca parent virus and the remaining seven RNA segments from the A/Korea/1/82 (H3N2) wild-type virus parent. These were evaluated in vitro for their ca and ts phenotypes and in ferrets, hamsters, and seronegative adult volunteers for the att phenotype. We found that the polymerase PA gene of the ca parent specifies the ca phenotype and that the PB2 and PB1 genes independently specify the ts phenotype. The PA, M, PB2, and PB1 genes of the ca donor virus each contribute to the att phenotype. The finding that four genes of the ca donor virus contribute to the att phenotype provides a partial explanation for the observed phenotypic stability of ca reassortant viruses following replication in humans.

Full text

PDF
489

Images in this article

490Image
on p.490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belshe R. B., Van Voris L. P. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis. 1984 May;149(5):735–740. doi: 10.1093/infdis/149.5.735. [DOI] [PubMed] [Google Scholar]
  2. Boulikas T., Hancock R. A highly sensitive technique for staining DNA and RNA in polyacrylamide gels using silver. J Biochem Biophys Methods. 1981 Oct;5(4):219–228. doi: 10.1016/0165-022x(81)90046-4. [DOI] [PubMed] [Google Scholar]
  3. Chanock R. M., Murphy B. R. Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease. Rev Infect Dis. 1980 May-Jun;2(3):421–432. doi: 10.1093/clinids/2.3.421. [DOI] [PubMed] [Google Scholar]
  4. Clements M. L., Betts R. F., Maassab H. F., Murphy B. R. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers. J Infect Dis. 1984 May;149(5):814–815. doi: 10.1093/infdis/149.5.814. [DOI] [PubMed] [Google Scholar]
  5. Cox N. J., Maassab H. F., Kendal A. P. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug;97(1):190–194. doi: 10.1016/0042-6822(79)90386-6. [DOI] [PubMed] [Google Scholar]
  6. Feldman S., Wright P. F., Webster R. G., Roberson P. K., Mahoney J., Thompson J., Doolittle M., Lott L., Johnson P., Christoph R. C. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J Infect Dis. 1985 Dec;152(6):1212–1218. doi: 10.1093/infdis/152.6.1212. [DOI] [PubMed] [Google Scholar]
  7. Johnson P. R., Jr, Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 1985 Dec;17(4):325–335. doi: 10.1002/jmv.1890170405. [DOI] [PubMed] [Google Scholar]
  8. Maassab H. F., Kendal A. P., Abrams G. D., Monto A. S. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis. 1982 Dec;146(6):780–790. doi: 10.1093/infdis/146.6.780. [DOI] [PubMed] [Google Scholar]
  9. McCahon D., Beare A. S., Schild G. C., Hall T. S. Use of recombination in the production of influenza vaccine strains. Postgrad Med J. 1973 Mar;49(569):195–199. doi: 10.1136/pgmj.49.569.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murphy B. R., Buckler-White A. J., London W. T., Harper J., Tierney E. L., Miller N. T., Reck L. J., Chanock R. M., Hinshaw V. S. Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses. J Infect Dis. 1984 Dec;150(6):841–850. doi: 10.1093/infdis/150.6.841. [DOI] [PubMed] [Google Scholar]
  11. Murphy B. R., Chanock R. M., Clements M. L., Anthony W. C., Sear A. J., Cisneros L. A., Rennels M. B., Miller E. H., Black R. E., Levine M. M. Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun. 1981 May;32(2):693–697. doi: 10.1128/iai.32.2.693-697.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy B. R., Clements M. L., Madore H. P., Steinberg J., O'Donnell S., Betts R., Demico D., Reichman R. C., Dolin R., Maassab H. F. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May;149(5):816–816. doi: 10.1093/infdis/149.5.816. [DOI] [PubMed] [Google Scholar]
  13. Murphy B. R., Clements M. L., Tierney E. L., Black R. E., Stienberg J., Chanock R. M. Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers. J Infect Dis. 1985 Jul;152(1):225–229. doi: 10.1093/infdis/152.1.225. [DOI] [PubMed] [Google Scholar]
  14. Murphy B. R., Phelan M. A., Nelson D. L., Yarchoan R., Tierney E. L., Alling D. W., Chanock R. M. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981 Mar;13(3):554–560. doi: 10.1128/jcm.13.3.554-560.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murphy B. R., Rennels M. B., Douglas R. G., Jr, Betts R. F., Couch R. B., Cate T. R., Jr, Chanock R. M., Kendal A. P., Maassab H. F., Suwanagool S. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun. 1980 Aug;29(2):348–355. doi: 10.1128/iai.29.2.348-355.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Odagiri T., DeBorde D. C., Maassab H. F. Cold-adapted recombinants of influenza A virus in MDCK cells. I. Development and characterization of A/Ann Arbor/6/60 X A/Alaska/6/77 recombinant viruses. Virology. 1982 May;119(1):82–95. doi: 10.1016/0042-6822(82)90067-8. [DOI] [PubMed] [Google Scholar]
  17. Odagiri T., Tosaka A., Ishida N., Maassab H. F. Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene. Arch Virol. 1986;88(1-2):91–104. doi: 10.1007/BF01310893. [DOI] [PubMed] [Google Scholar]
  18. Reeve P., Almond J. W., Felsenreich V., Pibermann M., Maassab H. F. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. I. biologic, genetic, and biochemical characterization. J Infect Dis. 1980 Dec;142(6):850–856. doi: 10.1093/infdis/142.6.850. [DOI] [PubMed] [Google Scholar]
  19. Richman D. D., Murphy B. R. The association of the temperature-sensitive phenotype with viral attenuation in animals and humans: implications for the development and use of live virus vaccines. Rev Infect Dis. 1979 May-Jun;1(3):413–433. doi: 10.1093/clinids/1.3.413. [DOI] [PubMed] [Google Scholar]
  20. Snyder M. H., Buckler-White A. J., London W. T., Tierney E. L., Murphy B. R. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol. 1987 Sep;61(9):2857–2863. doi: 10.1128/jvi.61.9.2857-2863.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snyder M. H., Clements M. L., Betts R. F., Dolin R., Buckler-White A. J., Tierney E. L., Murphy B. R. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol. 1986 May;23(5):852–857. doi: 10.1128/jcm.23.5.852-857.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Snyder M. H., Clements M. L., De Borde D., Maassab H. F., Murphy B. R. Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus. J Clin Microbiol. 1985 Nov;22(5):719–725. doi: 10.1128/jcm.22.5.719-725.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Spring S. B., Maassab H. F., Kendal A. P., Murphy B. R., Chanock R. M. Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain. Arch Virol. 1977;55(3):233–246. doi: 10.1007/BF01319909. [DOI] [PubMed] [Google Scholar]
  24. Tian S. F., Buckler-White A. J., London W. T., Reck L. J., Chanock R. M., Murphy B. R. Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract. J Virol. 1985 Mar;53(3):771–775. doi: 10.1128/jvi.53.3.771-775.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tolpin M. D., Massicot J. G., Mullinix M. G., Kim H. W., Parrott R. H., Chanock R. M., Murphy B. R. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. Virology. 1981 Jul 30;112(2):505–517. doi: 10.1016/0042-6822(81)90298-1. [DOI] [PubMed] [Google Scholar]
  26. Wright P. F., Okabe N., McKee K. T., Jr, Maassab H. F., Karzon D. T. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis. 1982 Jul;146(1):71–79. doi: 10.1093/infdis/146.1.71. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES